bucindolol has been researched along with Chronic Illness in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 6 (66.67) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aban, IB; Ahmed, A; Ahmed, MI; Aronow, WS; Bogaard, HJ; Deedwania, P; Desai, RV; Feller, MA; Fonarow, GC; Guichard, JL; Iskandrian, AE; Meyer, P; Mujib, M; Waagstein, F; White, M | 1 |
Fiuzat, M; O'Connor, CM | 1 |
Coats, AJ | 1 |
Abraham, WT; Bristow, MR; Crisman, TS; Gilbert, EM; Hattler, BG; Larrabee, P; Lowes, BD; Robertson, AD; White, M; Yoshikawa, T | 1 |
Bristow, MR | 1 |
Bristow, MR; Domanski, MJ; Eichhorn, EJ; Krause-Steinrauf, H; Lavori, PW | 1 |
SoRelle, R | 1 |
Bosimini, E | 1 |
Czuriga, I; Edes, I | 1 |
4 review(s) available for bucindolol and Chronic Illness
Article | Year |
---|---|
Bucindolol: new hopes from reviewing past data.
Topics: Adrenergic beta-Antagonists; Chronic Disease; Clinical Trials as Topic; Heart Failure; Humans; Propanolamines | 2011 |
Beta-adrenoceptor antagonists in elderly patients with chronic heart failure: therapeutic potential of third-generation agents.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Benzopyrans; Carbazoles; Carvedilol; Chronic Disease; Ethanolamines; Heart Failure; Humans; Nebivolol; Practice Guidelines as Topic; Propanolamines; Randomized Controlled Trials as Topic | 2006 |
beta-adrenergic receptor blockade in chronic heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Heart Failure; Heart Function Tests; Humans; Metoprolol; Propanolamines; Receptors, Adrenergic, beta; Signal Transduction | 2000 |
[Role of beta-blockers in the treatment of chronic heart heart failure].
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Controlled Clinical Trials as Topic; Disease Progression; Drug Administration Schedule; Heart Failure; Humans; Metoprolol; Myocardial Contraction; Patient Selection; Propanolamines; Survival Rate; Ventricular Dysfunction, Left; Ventricular Function, Left | 2001 |
3 trial(s) available for bucindolol and Chronic Illness
Article | Year |
---|---|
Reduced right ventricular ejection fraction and increased mortality in chronic systolic heart failure patients receiving β-blockers: insights from the BEST trial.
Topics: Adrenergic beta-Antagonists; Aged; Chronic Disease; Female; Heart Failure, Systolic; Humans; Male; Middle Aged; Propanolamines; Stroke Volume; Treatment Outcome; Ventricular Function, Right | 2013 |
Second- and third-generation beta-blocking drugs in chronic heart failure.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Carbazoles; Cardiac Output, Low; Cardiomyopathy, Dilated; Carvedilol; Chronic Disease; Exercise Test; Heart Ventricles; Hemodynamics; Humans; Metoprolol; Middle Aged; Myocardial Ischemia; Oxygen Consumption; Propanolamines; Ventricular Function, Left | 1997 |
A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure.
Topics: Adrenergic beta-Antagonists; Aged; Chronic Disease; Double-Blind Method; Female; Heart Failure; Heart Transplantation; Hospitalization; Humans; Male; Middle Aged; Propanolamines; Proportional Hazards Models; Severity of Illness Index; Survival Analysis | 2001 |
2 other study(ies) available for bucindolol and Chronic Illness
Article | Year |
---|---|
Beta-blocker trials seem to be in conflict.
Topics: Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Chronic Disease; Contraindications; Heart Failure; Humans; Propanolamines; Randomized Controlled Trials as Topic; Survival Rate; Treatment Outcome | 2001 |
[Effect of carvedilol on survival in severe chronic heart failure. A trial of the beta-blocker bucindolol in patient with advanced heart failure].
Topics: Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Chronic Disease; Clinical Trials as Topic; Heart Failure; Humans; Propanolamines; Severity of Illness Index; Survival Rate | 2001 |